Benitec Biopharma Ltd (BNTC)
NASDAQ:BNTC
Holding BNTC?
Track your performance easily

Benitec Biopharma (BNTC) Financial Statements

234 Followers

Benitec Biopharma Financial Overview

Benitec Biopharma's market cap is currently ―. The company's EPS TTM is $-7.563; its P/E ratio is -1.40; Benitec Biopharma is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Mar 23Dec 22
Income Statement-
Total Revenue---$ 54.00K-
Gross Profit-$ -1.00K$ 106.00K$ 54.00K-
EBIT$ -4.28M$ -6.79M$ -5.95M$ -4.40M-
EBITDA$ -4.19M$ -6.71M$ -5.87M$ -4.30M-
Net Income Common Stockholders$ -4.28M$ -6.80M$ -5.95M$ -4.40M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 20.40M$ 25.90M$ 6.60M$ 10.50M
Total Assets$ 15.00M$ 21.35M$ 27.05M$ 8.22M$ 11.90M
Total Debt$ 354.00K$ 423.00K$ 491.00K$ 623.00K$ 685.00K
Net Debt$ 354.00K$ -19.98M$ -25.41M$ -5.98M$ -9.81M
Total Liabilities$ 3.50M$ 5.88M$ 4.75M$ 3.51M$ 2.91M
Stockholders Equity$ 11.50M$ 15.47M$ 22.31M$ 4.71M$ 8.99M
Cash Flow-
Free Cash Flow$ -6.38M$ -5.37M$ -4.58M$ -4.03M-
Operating Cash Flow$ -6.20M$ -5.37M$ -4.58M$ -4.03M-
Investing Cash Flow$ -179.00K----
Financing Cash Flow-$ 39.00K$ 27.92M--
Currency in USD

Benitec Biopharma Earnings and Revenue History

Benitec Biopharma Debt to Assets

Benitec Biopharma Cash Flow

Benitec Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis